The ocean in which we float

Harassment in oncology is pervasive—just look at the data

By Stephanie L. Graff, Ishwaria Subbiah, Merry Jennifer Markham, Laurie Beth Matt-Amaral, Julia Lee Close, Kent A. Griffith and Reshma Jagsi

In the days leading up to the 2021 American Society of Clinical Oncology annual meeting, The Cancer Letter published a piece focused on Axel Grothey’s unethical sexual relationships with women he mentored while at Mayo Clinic. While this news was met by some as shocking, science tells us it is anything but.

The ocean in which we float

Narjust Duma: “To all minority fellows, residents, and medical students—you belong in medicine”

RIP MTD: FDA to require sponsors to determine optimal dosage before initiating pivotal trials in cancer

Optimize the dose: An optimal step forward for FDA

COTA’s Miruna Sasu: I left pharma to “turn the spigot on” in the real-world data industry

Roswell Park, MD Anderson, Memorial Sloan Kettering: The cancer centers that set the model for a nation

In Brief

Caryn Lerman steps in as president of AACI

FDA crowdsources research questions to be addressed through FDA oncologic clinical trial data

Joseph A. Sparano named chief of hematology and medical oncology, deputy director of Tisch Cancer Institute

Edward Kim named medical director of clinical research at UC Davis

David Klimstra named CMO of Paige

Bridget F. Koontz, Neal D. Shore named CMOs of GenesisCare

Friends of Cancer Research launches Step 2 of the ctMoniTR Project

City of Hope enters product license agreement with ProBioGen AG for COVID vaccine manufacturing

Clinical Roundup

Phase III KEYNOTE-564 trial: Keytruda after surgery reduced risk of recurrence or death by 32% in RCC

Comprehensive genomic and transcriptomic profiling predicts pan-tumor benefit of Keytruda

Phase III TULIP study meets primary endpoint of PFS in HER2-positive unresectable locally advanced or metastatic breast cancer

Fox Chase researchers find racial disparities in prostate cancer surgery rates during COVID-19

Roswell Park team demonstrates safe approach for dramatically reducing opioid use after surgery

Researchers find benefit from checkpoint inhibitors in sarcomatoid kidney cancer

Yale Cancer Center study: Novel test can detect new and recurrent bladder Cancer

PATHFINDER study: Galleri blood test can detect cancers before symptoms arise

Phase II glioblastoma study shows vaccine improves PFS

Study: Advanced multi-omics platform predicts superior OS and DFS for in glioblastoma

Drugs & Targets

Galen platform receives FDA Breakthrough Device Designation

BIG, EORTC, AFT collaborate with Sanofi to study amcenestrant in the adjuvant setting for estrogen receptor-positive breast cancer

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login